Daily Judi: Tuesday, December 6, 2022
Every day we scan the headlines for the best items that engage the clinical trial ecosystem, workflow solutions, and more—all the latest news you need to know. Here are today's stories:
A JAMA survey of 100 clinical trials indicates that in human studies of COVID-19 vaccines, women and historically marginalized groups were under-represented. (Axios)
Gwendolyn Wu looks at new biotech company, Entact Bio. Headed by former Sanofi executive Victoria Richona, Entact Bio recently secured $81 million in Series A financing, and will focus on treating diseases by restoring beneficial proteins. (BioPharma Dive)
Angela Spivey speaks with Bobby Warren, MPS, the director of Duke's Disinfection, Resistance, and Transmission Epidemiology lab (DiRTE), and Deverick J. Anderson, MD, MPH, head of Duke Center for Antimicrobial Stewardship and Infection Prevention. In a randomized clinical trial, surfaces cleaned with enhanced methods had significantly lower contaminants than when using typical hospital cleaners. In the United States, 75,000 hospital patients die each year of health care-associated infections. (Duke University School of Medicine)
Our Culture
“Dossiers and redaction are built within the Judi platform, which helps significantly with adjudication management—and the client collaborates on the process.”
–Jess, Program Manager
About Judi
Judi speeds and improves the world's clinical trial workflows. Our cloud-based platform has 120,000 users across 168 countries. We eliminate the chaos so clinical teams can focus on the patient, rather than the process. We are a SOC 2 Type II certified collaboration platform.
